Biotricity director Stephen Salmon resigns; Ronald McClurg appointed to board

BIOTRICITY INC.

Stephen Salmon resigned from board and compensation committee effective May 2, 2022; no disagreement cited.
Ronald McClurg appointed on May 4, 2022 to fill vacancy; will receive standard non-employee director compensation.
McClurg was VP Finance & Administration/CFO of Incisive Surgical from 2003-2019; consultant since 2020.
No material transaction interests or committee assignments disclosed for McClurg.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Stephen Salmon

Director

BTCY · BIOTRICITY INC.

Effective: 2022-05-02
Successor: Ronald McClurg
Filed: May 6, 2022, 7:59 PM ET

On May 2, Stephen Salmon a member of the Board of Directors of Biotricity Inc. (the “Company”) and the Company’s Compensation Committee, resigned from the Company’s Board of Directors effective May 2, 2022.

Appointed

Ronald McClurg

Director

BTCY · BIOTRICITY INC.

Effective: 2022-05-04
Filed: May 6, 2022, 7:59 PM ET

On May 4, 2022, the Board of Directors of the Company appointed Ronald McClurg to the Board of Directors to fill the vacancy created by Mr. Salmon’s resignation.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Stephen Salmon resigned as Director at BIOTRICITY INC..

Action: resigned
Role: Director

Exact text from the filing

On May 2, Stephen Salmon a member of the Board of Directors of Biotricity Inc. (the “Company”) and the Company’s Compensation Committee, resigned from the Company’s Board of Directors effective May 2, 2022.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Ronald McClurg was appointed as Director at BIOTRICITY INC..

Action: appointed
Role: Director

Exact text from the filing

On May 4, 2022, the Board of Directors of the Company appointed Ronald McClurg to the Board of Directors to fill the vacancy created by Mr. Salmon’s resignation.

View on SEC.gov

BIOTRICITY INC. filing history →

Source: SEC EDGAR

accession 0001493152-22-012395

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.